
88.47 Delayed Data As of May 18 | ![]() Today’s Change | 82.51 Today|||52-Week Range 120.54 | -17.90% Year-to-Date |
The 12 analysts offering 12-month price forecasts for Horizon Therapeutics PLC have a median target of 140.00, with a high estimate of 162.00 and a low estimate of 132.00. The median estimate represents a +58.25% increase from the last price of 88.47.
The current consensus among 12 polled investment analysts is to Buy stock in Horizon Therapeutics PLC. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.